Advertisement
Skip to Content

Diasorin SpA DSRLF Stock Quote

| Rating as of

PINX: DSRLF

Last close prices updated as of Jan 06, 2023, 10:32 AM EST | USD
  • Last Close 132.9
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Mid Growth
  • Day Range 132.90  –  132.90
  • Year Range 107.00  –  156.00
  • Market Cap 7.1549 Bil
  • Volume / Avg 30.0 /  87.0
  • Price / Sales 4.72
  • Price / Book 4.03
  • Forward Div Yield 0.85%
  • Trailing Div Yield 0.79%

Morningstar‘s Stock Analysis DSRLF

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics DSRLF

Company Profile DSRLF

Business Description

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics--testing done on samples taken from the human body, such as blood and issue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (55% of sales) and molecular diagnostics (35%) and has a total installed base of over 9,000 diagnostic systems. Licensed technologies contribute the remaining 10% of total sales, DiaSorin has a strong presence in Europe, the Middle East, and Africa; the region accounts for the largest portion of company revenue (44%), followed by North America (41%), Asia-Pacific (11%), and Latin America (4%).

Contact
Via Crescentino Snc, Saluggia
Vercelli, 13040, ITA
Industry Diagnostics & Research
Employees 3,358

FAQs for Diasorin SpA Stock

Yes. DSRLF has a forward dividend yield of 0.85%. See DSRLF’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

DSRLF’s market cap is 7.15 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

DSRLF’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

DSRLF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare DSRLF’s historical performance against its industry peers and the overall market.